The agent does the work. Your team approves it.

Carelane runs the whole trial in one system, from the first protocol upload to the final export. The agent drafts the build, suggests values from source documents and prepares queries and reports, and your team decides what goes in.

Live demo

Build the data collection from the protocol

Protocol HF-301 v2.0

Draftv1You, today

Read by AI: 48 pages, 6 tables.

Clinical Study Protocol HF-301

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicentre study to evaluate the efficacy and safety of NWC-401 10 mg once daily in adults with heart failure with reduced ejection fraction (HFrEF)

ItemDetail
Protocol numberHF-301
Version2.0 (Amendment 1), 14 February 2026
SupersedesVersion 1.0, 10 June 2025
SponsorNorthwind Cardio Therapeutics
Contract research organizationMeridian Clinical Research
Investigational medicinal productNWC-401 10 mg film-coated tablet
ComparatorMatching placebo tablet
Phase3
Page 4
1. Synopsis

HF-301 is a 28-week study in approximately 400 adults with chronic, symptomatic HFrEF who remain symptomatic despite optimised guideline-directed medical therapy. Participants are randomized 1:1 to NWC-401 10 mg or matching placebo, taken orally once daily for 24 weeks, followed by a 4-week off-treatment follow-up period. The study is conducted at 8 sites in the United States, Spain, Italy and the Netherlands.

Page 17
6. Schedule of activities
AssessmentScreeningBaselineWeek 4Week 12Week 24Follow-up W28
Visit windowDay −14 to −3Day 1Day 29 ± 3Day 85 ± 5Day 169 ± 7Day 197 ± 7
Informed consentX
Eligibility reviewXX
Randomization (IWRS)X
NYHA functional classXXXXX
Vital signsXXXXXX
6-minute walk testXXX
NT-proBNP (central laboratory)XXXX
Serum potassium and creatinine (central laboratory)XXXXX
Adverse event reviewXXXXX
Study drug dispensing and accountabilityXXX

Visit windows are relative to Day 1 (Baseline). Screening assessments may be spread over more than one day within the window. Central laboratory samples are taken before study drug administration.

Page 21
8.4 NYHA class, vital signs and safety laboratory

The investigator assesses NYHA functional class at every visit up to Week 24. Blood pressure and heart rate are measured seated after 5 minutes of rest; body weight is measured without shoes. Serum potassium and creatinine are measured by the central laboratory at Screening, Baseline, Week 4, Week 12 and Week 24.

sites
250+
countries
50+
continents
6
Sites that have worked in Carelane2026

What Carelane is

A change is made once, and everyone on the study reads the same data.

When a trial runs on several systems, people spend their time reconciling between them.

Your team

Accepts or rejects, signs and approves

The agent

Drafts and suggests, within the settings you choose

One workspace

  • EDC
  • eCOAPartial
  • eTMF
  • Randomization
  • Site management
  • Reports

One study record

Design and CRF versions · Participant data · Documents · Audit trail

Export in open formatsCSV · FHIR JSON · SDTM (CSV per domain) · Casebook PDF · Markdown or PDF per record

What each module covers

01Changing a study that is already running

Amendments without a rebuild

A change to an eCRF becomes a new CRF version. You can see what it does at each site before anything moves, the agent drafts the release notes, and an approver signs to take it live.

Approving is reserved for people, so if you ask the agent to do it, it will refuse.

Try it

  1. 1Accept the change the agent suggests for the Vital signs eCRF.
  2. 2Request go-live, then continue as the approver.
  3. 3Ask the agent to approve it, then sign it yourself.

Live demo

02Reading values from source documents

Clean data sooner

Site staff drop in a discharge letter or a lab report, and the agent suggests a value for each field it can match. A value is entered once someone accepts it, and edit checks run as the data comes in.

Try it

  1. 1Drop the discharge letter on the eCRF.
  2. 2Accept the values you agree with. Each one shows the passage it was taken from.
  3. 3Type 95 into LVEF to see an edit check.

Live demo

03Asking questions about the study data

Real-time reporting

A study manager can ask a question in plain language and get a report built from the study’s data. Any figure in it can be opened to see the query and the records it came from.

Try it

  1. 1Ask for 12-month outcomes by heart failure type.
  2. 2Click a figure to see how it was computed and which records are behind it.

Live demo

04Control

The audit trail of what you just did

Everything you accepted, rejected or signed in the demos above is listed here, the way a study’s audit trail shows it.

  • AI control

    Approving, signing, deploying, publishing and changing members are reserved for people, and the agent is refused if it is asked to do any of them. For everything else you set, area by area, whether the agent can make changes or only suggest them. A suggestion that someone accepts is saved under that person’s name.

  • Ownership

    The study team can export study data from inside the product as CSV, FHIR JSON and SDTM.

How the agent is controlled

See Carelane in a demo

We'll show you the product on a sample study and answer your questions.

  • We walk through study build, data capture and reports on a sample study.
  • There is time for your questions, and for your QA or IT colleagues if they join.
  • You don't need to prepare or send us anything.